NVAX Market Cap & Key Metrics
Novavax, Inc.
$11.66
+$0.33(+2.96%)
69
Overall
60
Value
100
Tech
47
Quality
Market Cap
$1.87B
Volume
2.47M
52W Range
$6.20 - $11.97
Target Price
$13.70
NVAX market cap is $1.87B. This page lists Novavax, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
NVAX Key Metrics
- Market cap
- $1.87B
- EPS estimate, current year
- $-0.46
- EPS growth, 3-year
- +32.44%
- Value score
- 60
- Quality score
- 47
- Technical score
- 100
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.12B | $682.16M | $983.71M | $1.98B | $1.15B |
| EBITDA | $492.33M | -$108.04M | -$487.39M | -$604.71M | -$1.68B |
| EPS | $2.72 | $-1.23 | $-5.41 | $-8.42 | $-23.44 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVAX | $11.66 | +3.0% | 2.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |